NEW YORK (GenomeWeb) – Benchling announced yesterday that it has raised $7 million in a private financing round led by Thrive Capital with participation from existing investor Andreessen Horowitz and angel investors Errik Anderson and Ashton Kutcher.

The digital lab notebook software company said it would use the funding to further invest in its products — which include a design tool for CRISPR guide RNAs and a bioregistry for tracking biological entities — as well as to scale its scientific operations.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.